HomeCompareSTBBF vs JNJ

STBBF vs JNJ: Dividend Comparison 2026

STBBF yields 3.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STBBF wins by $5.31M in total portfolio value
10 years
STBBF
STBBF
● Live price
3.00%
Share price
$97.45
Annual div
$2.93
5Y div CAGR
74.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.34M
Annual income
$4,275,651.80
Full STBBF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — STBBF vs JNJ

📍 STBBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTBBFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STBBF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STBBF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STBBF
Annual income on $10K today (after 15% tax)
$255.40/yr
After 10yr DRIP, annual income (after tax)
$3,634,304.03/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, STBBF beats the other by $3,630,266.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STBBF + JNJ for your $10,000?

STBBF: 50%JNJ: 50%
100% JNJ50/50100% STBBF
Portfolio after 10yr
$2.69M
Annual income
$2,140,200.84/yr
Blended yield
79.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STBBF
No analyst data
Altman Z
2.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STBBF buys
0
JNJ buys
0
No recent congressional trades found for STBBF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTBBFJNJ
Forward yield3.00%2.14%
Annual dividend / share$2.93$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR74.5%28%
Portfolio after 10y$5.34M$30.5K
Annual income after 10y$4,275,651.80$4,749.88
Total dividends collected$5.23M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STBBF vs JNJ ($10,000, DRIP)

YearSTBBF PortfolioSTBBF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,224$524.32$10,594$274.49+$630.00STBBF
2$12,970$959.78$11,294$360.69+$1.7KSTBBF
3$15,686$1,808.65$12,133$476.91+$3.6KSTBBF
4$20,352$3,567.42$13,156$635.42+$7.2KSTBBF
5$29,325$7,548.27$14,432$854.61+$14.9KSTBBF
6$49,115$17,737.40$16,056$1,162.76+$33.1KSTBBF
7$101,001$48,448.52$18,175$1,604.53+$82.8KSTBBF
8$270,554$162,482.62$21,009$2,252.68+$249.5KSTBBF
9$999,308$709,815.29$24,911$3,229.73+$974.4KSTBBF
10$5,344,912$4,275,651.80$30,458$4,749.88+$5.31MSTBBF

STBBF vs JNJ: Complete Analysis 2026

STBBFStock

Strabag SE, together with its subsidiaries, operates as a construction company. The company engages in the construction of road, rail, and canal bridges; commercial and industrial facilities; hydroelectric power plants, storage power plants, hydraulic power plants, concrete gravity dams, earth-filled and rock-filled embankment dams, reservoirs, external asphalt sealing, asphalt core sealing, thermal power plants, wind farms, and electrical substations; and administration buildings, events and cultural centers, museums, hospitals, rehabilitation centers, retirement and nursing homes, universities, schools, kindergartens, fire and rescue centers, and churches. It also constructs prefabricated elements, civil engineering projects, metal constructions, water environmental technologies, and housing projects. In addition, the company undertakes transportation infrastructure projects, including railway construction, construction material, sewer engineering, pipe and sewer construction, town planning and landscape architecture, paving, large surfaces, rock engineering and protective structures, ground engineering, sports and recreational facilities, road construction, earthworks, traffic engineering, and waterway construction projects. Further, it undertakes infrastructure development; engages in the operation, maintenance, and marketing of public-private partnerships projects; and provision of real estate development and tunneling services, as well as property and facility services, such as property management and corporate real estate solutions, area management, renting and letting, technical facility management and building management, infrastructural facility management, and industrial services. The company offers its services primarily in Europe, the Arabian Peninsula, Africa, Asia, and the Americas. Strabag SE was founded in 1835 and is headquartered in Villach, Austria.

Full STBBF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this STBBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STBBF vs SCHDSTBBF vs JEPISTBBF vs OSTBBF vs KOSTBBF vs MAINSTBBF vs ABBVSTBBF vs MRKSTBBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.